* Ingevity Corp NGVT.N reported quarterly adjusted
earnings of
95 cents per share for the quarter ended December 31, higher
than the same quarter last year, when the company reported EPS
of 21 cents. The mean expectation of four analysts for the
quarter was for earnings of 31 cents per share. Wall Street
expected results to range from 12 cents to 48 cents per share.
* Revenue fell 19.6% to $298.80 million from a year ago;
analysts
expected $310.80 million.
* Ingevity Corp's reported EPS for the quarter was 46
cents.
* The company reported quarterly net income of $16.6
million.
* Ingevity Corp shares had risen by 10.7% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 6% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the diversified
chemicals peer group is also "buy"
Wall Street's median 12-month price target for Ingevity Corp is
$55.50
This summary was machine generated from LSEG data February 18 at
10:36 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 0.31 0.95 Beat
Sep. 30 2024 0.90 1.10 Beat
Jun. 30 2024 1.05 1.01 Missed
Mar. 31 2024 0.32 0.52 Beat